The ASC transaction market remains active, but conditions are evolving. After a period of aggressive expansion and high valuations, the market is showing signs of stabilization.

Recent transactions place ASC valuation multiples generally between 6 and 10 times EBITDA, with premium assets exceeding that range in competitive situations. This reflects a modest contraction from peak multiples of 10 to 12 times observed in earlier cycles.

Private equity continues to dominate acquisition activity, accounting for more than 60 percent of transactions in recent years. These platforms are focused on building scale through multi center portfolios and regional consolidation strategies.

Deal structures are becoming more sophisticated. Sellers frequently retain minority ownership positions, often between 20 and 40 percent, allowing participation in future value creation. Earn out provisions and performance based payments are also increasingly common.

Financing conditions have shifted. Interest rates remain elevated relative to pre 2020 levels, increasing the cost of leveraged acquisitions. Debt typically represents 50 to 70 percent of transaction value, making financing terms a key determinant of deal feasibility.

Strategic buyers, including hospital systems, remain active but are increasingly focused on partnership structures rather than full acquisitions.

For physician owners, asset quality is critical. Centers with diversified case mix, efficient operations, and stable referral patterns command premium valuations. Those with operational weaknesses or concentrated referral sources face valuation discounts.

The market remains attractive, but more selective. Buyers are conducting deeper analysis of earnings quality, payer mix, and operational metrics.

ASC ownership continues to represent one of the most valuable positions in healthcare. Understanding market dynamics is essential for maximizing exit value.